Literature DB >> 22234961

Aryl hydrocarbon receptor regulates the cholesterol biosynthetic pathway in a dioxin response element-independent manner.

Rachel Tanos1, Rushang D Patel, Iain A Murray, Philip B Smith, Andrew D Patterson, Gary H Perdew.   

Abstract

UNLABELLED: The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor. Activation of AhR mediates the expression of target genes (e.g., CYP1A1) by binding to dioxin response element (DRE) sequences in their promoter region. To understand the multiple mechanisms of AhR-mediated gene regulation, a microarray analysis on liver isolated from ligand-treated transgenic mice expressing a wild-type (WT) Ahr or a DRE-binding mutant Ahr (A78D) on an ahr-null background was performed. Results revealed that AhR DRE binding is not required for the suppression of genes involved in cholesterol synthesis. Quantitative reverse-transcription polymerase chain reaction performed on both mouse liver and primary human hepatocyte RNA demonstrated a coordinated repression of genes involved in cholesterol biosynthesis, namely, HMGCR, FDFT1, SQLE, and LSS after receptor activation. An additional transgenic mouse line was established expressing a liver-specific Ahr-A78D on a Cre(Alb)/Ahr(flox/flox) background. These mice displayed a similar repression of cholesterol biosynthetic genes, compared to Ahr(flox/flox) mice, further indicating that the observed modulation is AhR specific and occurs in a DRE-independent manner. Elevated hepatic transcriptional levels of the genes of interest were noted in congenic C57BL/6J-Ah(d) allele mice, when compared to the WT C57BL/6J mice, which carry the Ah(b) allele. Down-regulation of AhR nuclear translocator levels using short interfering RNA in a human cell line revealed no effect on the expression of cholesterol biosynthetic genes. Finally, cholesterol secretion was shown to be significantly decreased in human cells after AhR activation.
CONCLUSION: These data firmly establish an endogenous role for AhR as a regulator of the cholesterol biosynthesis pathway independent of its DRE-binding ability, and suggest that AhR may be a previously unrecognized therapeutic target.
Copyright © 2012 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22234961      PMCID: PMC3340481          DOI: 10.1002/hep.25571

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  36 in total

1.  Co-stimulation of promoter for low density lipoprotein receptor gene by sterol regulatory element-binding protein and Sp1 is specifically disrupted by the yin yang 1 protein.

Authors:  M K Bennett; T T Ngo; J N Athanikar; J M Rosenfeld; T F Osborne
Journal:  J Biol Chem       Date:  1999-05-07       Impact factor: 5.157

Review 2.  Squalene synthase inhibitors : clinical pharmacology and cholesterol-lowering potential.

Authors:  Valentine Charlton-Menys; Paul N Durrington
Journal:  Drugs       Date:  2007       Impact factor: 9.546

3.  TCDD-induced anorexia and wasting syndrome in rats: effects of diet-induced obesity and nutrition.

Authors:  J T Tuomisto; R Pohjanvirta; M Unkila; J Tuomisto
Journal:  Pharmacol Biochem Behav       Date:  1999-04       Impact factor: 3.533

4.  7-ketocholesterol is an endogenous modulator for the arylhydrocarbon receptor.

Authors:  J F Savouret; M Antenos; M Quesne; J Xu; E Milgrom; R F Casper
Journal:  J Biol Chem       Date:  2000-10-20       Impact factor: 5.157

5.  The aryl hydrocarbon receptor directly regulates expression of the potent mitogen epiregulin.

Authors:  Rushang D Patel; Dae Joon Kim; Jeffrey M Peters; Gary H Perdew
Journal:  Toxicol Sci       Date:  2005-09-28       Impact factor: 4.849

6.  2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the mRNA expression of critical genes associated with cholesterol metabolism, bile acid biosynthesis, and bile transport in rat liver: a microarray study.

Authors:  Nick Fletcher; David Wahlström; Rebecca Lundberg; Charlotte B Nilsson; Kerstin C Nilsson; Kenneth Stockling; Heike Hellmold; Helen Håkansson
Journal:  Toxicol Appl Pharmacol       Date:  2005-08-22       Impact factor: 4.219

7.  Zinc finger transcription factor Slug is a novel target gene of aryl hydrocarbon receptor.

Authors:  Togo Ikuta; Kaname Kawajiri
Journal:  Exp Cell Res       Date:  2006-08-09       Impact factor: 3.905

Review 8.  Regulatory network of lipid-sensing nuclear receptors: roles for CAR, PXR, LXR, and FXR.

Authors:  Christoph Handschin; Urs A Meyer
Journal:  Arch Biochem Biophys       Date:  2005-01-15       Impact factor: 4.013

9.  Metabolism of retinoids and arachidonic acid by human and mouse cytochrome P450 1b1.

Authors:  Dharamainder Choudhary; Ingela Jansson; Ivaylo Stoilov; Mansoor Sarfarazi; John B Schenkman
Journal:  Drug Metab Dispos       Date:  2004-08       Impact factor: 3.922

10.  Lipid metabolism and neuropsychological follow-up study of workers exposed to 2,3,7,8- tetrachlordibenzo- p-dioxin.

Authors:  D Pelclová; Z Fenclová; J Preiss; B Procházka; J Spácil; Z Dubská; B Okrouhlík; E Lukás; P Urban
Journal:  Int Arch Occup Environ Health       Date:  2002-07-04       Impact factor: 3.015

View more
  45 in total

1.  Comparisons of differential gene expression elicited by TCDD, PCB126, βNF, or ICZ in mouse hepatoma Hepa1c1c7 cells and C57BL/6 mouse liver.

Authors:  Rance Nault; Agnes L Forgacs; Edward Dere; Timothy R Zacharewski
Journal:  Toxicol Lett       Date:  2013-08-29       Impact factor: 4.372

2.  Selective Ah receptor ligands mediate enhanced SREBP1 proteolysis to restrict lipogenesis in sebocytes.

Authors:  Gulsum E Muku; Nicholas Blazanin; Fangcong Dong; Philip B Smith; Diane Thiboutot; Krishne Gowda; Shantu Amin; Iain A Murray; Gary H Perdew
Journal:  Toxicol Sci       Date:  2019-06-21       Impact factor: 4.849

3.  Microbiome-derived tryptophan metabolites and their aryl hydrocarbon receptor-dependent agonist and antagonist activities.

Authors:  Un-Ho Jin; Syng-Ook Lee; Gautham Sridharan; Kyongbum Lee; Laurie A Davidson; Arul Jayaraman; Robert S Chapkin; Robert Alaniz; Stephen Safe
Journal:  Mol Pharmacol       Date:  2014-02-21       Impact factor: 4.436

4.  The Ah receptor regulates growth factor expression in head and neck squamous cell carcinoma cell lines.

Authors:  Kaarthik John; Tejas S Lahoti; Kelly Wagner; Jarod M Hughes; Gary H Perdew
Journal:  Mol Carcinog       Date:  2013-04-27       Impact factor: 4.784

5.  And Now for Something Completely Different: Diversity in Ligand-Dependent Activation of Ah Receptor Responses.

Authors:  Michael S Denison; Samantha C Faber
Journal:  Curr Opin Toxicol       Date:  2017-02

6.  Beyond the Aryl Hydrocarbon Receptor: Pathway Interactions in the Hepatotoxicity of 2,3,7,8-Tetrachlorodibenzo-p-dioxin and Related Compounds.

Authors:  Kelly A Fader; Timothy R Zacharewski
Journal:  Curr Opin Toxicol       Date:  2017-02-01

7.  Obesity and fatty liver are prevented by inhibition of the aryl hydrocarbon receptor in both female and male mice.

Authors:  Benjamin J Moyer; Itzel Y Rojas; Joanna S Kerley-Hamilton; Krishnamurthy V Nemani; Heidi W Trask; Carol S Ringelberg; Barjor Gimi; Eugene Demidenko; Craig R Tomlinson
Journal:  Nutr Res       Date:  2017-06-28       Impact factor: 3.315

8.  Diversity as Opportunity: Insights from 600 Million Years of AHR Evolution.

Authors:  Mark E Hahn; Sibel I Karchner; Rebeka R Merson
Journal:  Curr Opin Toxicol       Date:  2017-02-16

9.  Deletion or activation of the aryl hydrocarbon receptor alters adult hippocampal neurogenesis and contextual fear memory.

Authors:  Sarah E Latchney; Amy M Hein; M Kerry O'Banion; Emanuel DiCicco-Bloom; Lisa A Opanashuk
Journal:  J Neurochem       Date:  2013-01-07       Impact factor: 5.372

10.  Toxicogenomic evaluation of long-term hepatic effects of TCDD in immature, ovariectomized C57BL/6 mice.

Authors:  Anna K Kopec; Darrell R Boverhof; Rance Nault; Jack R Harkema; Colleen Tashiro; Dave Potter; Bonnie Sharratt; Brock Chittim; Timothy R Zacharewski
Journal:  Toxicol Sci       Date:  2013-07-17       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.